Drugs / GSC-DCV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04888611 | Oct 2021 → May 2023 | glioblastoma | Huashan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSC-DCV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04888611 ↗ |
| Route | Other | “GSC-DCV IH every 3 weeks” NCT04888611 ↗ |